TAB2 and familial dilated cardiomyopathy: Despite some limitations, we have, for the first time, established TAB2-knockout iPSC-derived cardiomyocytes using CRISPR/Cas9, discovered a novel mechanism of TAB2-knockout DCM, and improved the phenotype by inhibiting RIPK1.